Recursion (RXRX) Surges In Extended Session On An AI-Driven Update
Fahim Awan
April 11, 2025
Following a significant statement on its advancements in AI-enhanced drug development, shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) saw a large after-hours surge, rising 19.07%